Revitope
Company Details
Status: Private
Employees: 11-50
Location:
Cambridge, Massachusetts, United States
Type:
sample
Technology:
sample
sample
sample
About: Revitope is an early stage biotechnology company focused on developing the next-generation of T cell redirecting biologics.
Immune-based therapies are redefining how cancer is treated as clinical studies demonstrate unprecedented deep and durable responses in multiple cancers. In particular redirecting T cells to tumors is a successful strategy for immunotherapy of liquid tumors. However, unleashing a potent immune response that is entirely focused on the tumor continues to be elusive.
Revitope is developing a new class of biologic prodrugs we call Programmable Antibody Circuits or PACs that are engineered to focus immune activation to the cancer cell surface while expanding the antigenic targeting space.
Unlock access to company contacts, hot leads, and drug pipelines.
Log in or create a free account now!
Revitope | Active clinical trials on ClinicalTrials.gov
Active Clinical Trials Count | 0
No Active Trials Found On ClinicalTrials.gov.